Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

C-reactive Protein and Future Risk of Clinical and Molecular Subtypes of Colorectal Cancer

Stina Bodén, Robin Myte, Justin Harbs, Anneli Sundkvist, Carl Zingmark, Anna Löfgren Burström, Richard Palmqvist, Sophia Harlid and Bethany Van Guelpen
Stina Bodén
1Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stina Bodén
  • For correspondence: stina.boden@umu.se
Robin Myte
1Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robin Myte
Justin Harbs
1Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anneli Sundkvist
1Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl Zingmark
2Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Löfgren Burström
2Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Palmqvist
2Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophia Harlid
1Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sophia Harlid
Bethany Van Guelpen
1Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
3Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bethany Van Guelpen
DOI: 10.1158/1055-9965.EPI-19-1339 Published July 2020
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: April 2020 to January 2021

AbstractFull-text HTMLPDF
Total499472370

Cited By

Article Information

Volume 29, Issue 7, pp. 1482-1491

DOI 
https://doi.org/10.1158/1055-9965.EPI-19-1339
PubMed 
32317300

Published By 
American Association for Cancer Research
Print ISSN 
1055-9965
Online ISSN 
1538-7755
History 
  • Received October 30, 2019
  • Revision received January 27, 2020
  • Accepted April 17, 2020
  • Published first April 21, 2020.

Article Versions

  • Previous version (April 21, 2020 - 05:49).
  • Previous version (June 1, 2020 - 05:45).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2020 American Association for Cancer Research.

Author Information

  1. Stina Bodén1,*,
  2. Robin Myte1,
  3. Justin Harbs1,
  4. Anneli Sundkvist1,
  5. Carl Zingmark2,
  6. Anna Löfgren Burström2,
  7. Richard Palmqvist2,
  8. Sophia Harlid1, and
  9. Bethany Van Guelpen1,3
  1. 1Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  2. 2Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
  3. 3Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.
  1. ↵*Corresponding Author:
    Stina Bodén, Umeå University, 90187 Umeå, Sweden. Phone: 467-0595-3426; E-mail: stina.boden{at}umu.se
View Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 29 (7)
July 2020
Volume 29, Issue 7
  • Table of Contents
  • Table of Contents (PDF)
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
C-reactive Protein and Future Risk of Clinical and Molecular Subtypes of Colorectal Cancer
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
C-reactive Protein and Future Risk of Clinical and Molecular Subtypes of Colorectal Cancer
Stina Bodén, Robin Myte, Justin Harbs, Anneli Sundkvist, Carl Zingmark, Anna Löfgren Burström, Richard Palmqvist, Sophia Harlid and Bethany Van Guelpen
Cancer Epidemiol Biomarkers Prev July 1 2020 (29) (7) 1482-1491; DOI: 10.1158/1055-9965.EPI-19-1339

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
C-reactive Protein and Future Risk of Clinical and Molecular Subtypes of Colorectal Cancer
Stina Bodén, Robin Myte, Justin Harbs, Anneli Sundkvist, Carl Zingmark, Anna Löfgren Burström, Richard Palmqvist, Sophia Harlid and Bethany Van Guelpen
Cancer Epidemiol Biomarkers Prev July 1 2020 (29) (7) 1482-1491; DOI: 10.1158/1055-9965.EPI-19-1339
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Urinary Melatonin in Relation to Breast Cancer Risk
  • Endometrial Cancer and Ovarian Cancer Cross-Cancer GWAS
  • Risk Factors of Subsequent CNS Tumor after Pediatric Cancer
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement